Is Saxenda approved by the FDA?
Share
The U.S. Food and Drug Administration has approved Saxenda (liraglutide) for chronic weight management among patients aged 12 and older who are obese, as defined by specific body mass index (BMI) cut-offs for age and sex that correspond to a BMI 30 kg/m2 or higher for adults, and who weigh more than 60 kg (132 pounds).
shop now @ www.novomeds.shop
Saxenda Tirzepatide Ozempic Philippines